Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crexendo (CXDO) Asset Writedowns and Impairment (2022)

Crexendo's Asset Writedowns and Impairment history spans 2 years, with the latest figure at $32.7 million for Q4 2022.

  • For Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $32.7 million; the TTM value through Dec 2022 reached $32.7 million, changed N/A, while the annual FY2025 figure was -$73000.0, 157.48% down from the prior year.
  • Asset Writedowns and Impairment reached $32.7 million in Q4 2022 per CXDO's latest filing, up from $90000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $32.7 million in Q4 2022 to a low of $32.7 million in Q4 2022.